ADVI's Tyler Seville on how 340B grew from under $10 billion to over $100 billion annually — now larger than Medicaid and Medicare Part B.
Tyler Seville
Advertisement
Tyler Seville is associate director of market access policy strategy at ADVI.
Articles by Tyler Seville
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
2
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
3
BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies
4
What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates
5